July 11, 2024
Lawyers Claim Sam Bankman-Fried Requires Additional Adderall for Trial Focus
Latest Cryptocurrency News

Lawyers Claim Sam Bankman-Fried Requires Additional Adderall for Trial Focus

FTX co-founder Sam Bankman-Fried has requested a United States judge for long-release Adderall, stating that he’s experiencing difficulties concentrating properly during his ongoing criminal trial.

In an Oct. 15 letter addressed to New York District Judge Lewis Kaplan, Bankman-Fried’s legal team has asked for permission for him to take a “12-hour extended-release 20mg dose of Adderall” before his transportation to the trial scheduled for Oct. 16.

His lawyers expressed concerns that Bankman-Fried’s absence of the prescribed stimulant during trial hours has hindered his ability to “concentrate at the level he ordinarily would.”

With Bankman-Fried’s defense case nearing and the decision on whether he will testify, his legal team is worried that the FTX founder won’t be able to “meaningfully participate” in presenting his defense without the medication. Despite the absence of his medication during trial hours, the former FTX CEO has been “doing his best to remain focused during the trial,” as noted in the letter.

Even if Bankman-Fried takes the requested medication, his lawyers emphasized that there’s “no way of knowing at present whether the extended-release dose will be effective.”

Therefore, they have requested that the court pause the trial for one day, specifically on Tuesday, Oct. 17, should Bankman-Fried not be able to take the extended-release dose or if the medication doesn’t prove effective. This pause would allow time to “find a solution that will work for the remainder of the trial.”

Alternatively, the legal team has asked Judge Kaplan to permit them to provide Bankman-Fried with his prescription of Adderall at the District Court during the trial.

His lawyers asserted that they had made five attempts to contact the Bureau of Prisons between Oct. 5 and Oct. 12 but had received no response. It’s worth noting that Judge Kaplan initially approved a motion on Aug. 14, granting Bankman-Fried access to Adderall and anti-depressant medication. This approval came after his legal team cited his history of major depressive disorder and attention deficit hyperactivity disorder (ADHD) and his ongoing psychiatric care since early 2019.

Shortly after this initial approval, Bankman-Fried’s legal team raised concerns about his lack of access to medication during an Aug. 22 hearing, revealing that he had not received Adderall for the preceding 11 days.

Bankman-Fried’s criminal trial has now entered its third week, and the court has heard testimonies from individuals including former Alameda Research CEO and his ex-girlfriend Caroline Ellison, FTX co-founder Gary Wang, and a former developer for FTX, Adam Yedidia.

Throughout the trial, Bankman-Fried has pleaded not guilty and maintained his innocence.

Image by kjpargeter on Freepik

Disclosure Statement: Miami Crypto does not take any external funding, or support to bring crypto news to the readers. We do not have any conflicts of interest while writing news stories on Miami Crypto.

Related posts

Alameda Research’s 2021 USDT Redemption Spree Sparks Controversy

Anna Garcia

DeFi Drama: Nima Capital’s Role in Synapse’s Sharp SYN Token Decline

Harper Hall

Berlin’s Finoa Opens Regulatory-Compliant DeFi Access for Institutions

Kevin Wilson

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Please enter CoinGecko Free Api Key to get this plugin works.